Company page
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. is a public company traded under the ticker CRNX in the American market. The company has a market capitalization of approximately $8.87 billion. Crinetics focuses on developing innovative therapies for endocrine diseases and disorders.
- Ticker
- CRNX:NASDAQ
- Asset type
- Stock
- Market cap
- $8.87B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD